Monoclonal antibodies for infectious bursal disease, vaccines and assays for use therewith
AssigneeUniversity of Maryland
InventorDavid Snyder
Life of this patent
Estimating the term…
Abstract
Two monoclonal antibodies which neutralize all infectious bursal disease viruses are employed in the preparation of infectious bursal disease vaccines. A panel of monoclonal antibodies can be used to characterize the infectious bursal disease virus strains present, according to neutralization site characteristics.
Claims8
A monoclonal antibody which neutralizes GLS infectious bursal disease virus (IBDV) and at least one other infectious bursal disease virus type.
A monoclonal antibody which neutralizes GLS infectious bursal disease virus (IBDV) and at least one other infectious bursal disease virus type, expressed by cell line ATCC HB-10158.
A monoclonal antibody which neutralizes GLS infectious bursal disease virus (IBDV) and at least one other infectious bursal disease virus type, expressed by cell line ATCC HB-10174.
A cell line expressing the IBDV-specific monoclonal antibody of a cell line selected from the group consisting of ATCC deposits HB-10158-10174, HB-10157 and HB-10156.
Dependencies are inferred from the claim text.